ASF1B and neoplasm: Table 3 presents the tumor characteristics of the TCGA-LUAD patients in low- versus high-expression level groups of the ASF1B gene, and Table 4 shows the association between clinicopathological features of LUAD with ASF1B mRNA expression. As seen in Figures 2(e) and 2(h), ASF1B mRNA expression was significantly associated with four tumor characteristic variables including the N stage, pathologic stage, primary therapy outcome, and number of pack years smoked.